Chiratane Triterpenoid from the Rhizomes of Drynaria Fortunei

YH Liang,W Wang,M Ye,IA Khan,DA Guo
DOI: https://doi.org/10.1055/s-0031-1273560
IF: 3.007
2011-01-01
Planta Medica
Abstract:Drynaria fortunei (Kunze) J. Sm. (Polypodiaceae) is a fern indigenous to China. Its rhizomes named „Gu Sui Bu“, have been widely used for the treatment of osteoporosis and bone fracture as a famous Traditional Chinese Medicine [1]. Previous phytochemical investigations reported the isolation of some triterpenoids and flavonoids from D. fortunei [2–3]. Like most ferns, D. fortunei is abundant in triterpenoids, most of which are of the hopane and fernane skeletons. Our ongoing phytochemical study of D. fortunei resulted in the isolation of a new chiratane type triterpenoid chiratone (1), together with five known hopane titerpenoids, namely, fern-9(11)-ene, dryocrassol acetate, hop-22(29)-ene, dryocrassol, and isoglaucanone. Their cytotoxicities were evaluated. Compound 1 possessed significant cytotoxic activity against Hela, PC3 and Hep G2 cells, with IC50 of 2.92µM, 1.08µM and 2.45µM, respectively.
What problem does this paper attempt to address?